further study is necessary before widespread clinical use of heparin in diabetic nephropathy. Improved knowledge of the structure-function relationship of heparin and glycosaminoglycans and a doseresponse finding of these drugs might provide a unique opportunity to select new heparin derivatives with specific effects on diabetic nephropathy and possibly, most importantly, devoid of anticoagulant activity
Letter to the editor (multiple letters)
Gambaro G.;
1998-01-01
Abstract
further study is necessary before widespread clinical use of heparin in diabetic nephropathy. Improved knowledge of the structure-function relationship of heparin and glycosaminoglycans and a doseresponse finding of these drugs might provide a unique opportunity to select new heparin derivatives with specific effects on diabetic nephropathy and possibly, most importantly, devoid of anticoagulant activity
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
baggio1998.pdf
accesso aperto
Tipologia:
Versione dell'editore
Licenza:
Copyright dell'editore
Dimensione
37.07 kB
Formato
Adobe PDF
|
37.07 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
